Andrew J. Einhorn

Chief Financial Officer, MedAvail Holdings, Inc.

Companies

Pelthos Therapeutics Inc.Board member Dec 29, 2025 to now¹
COGNITION THERAPEUTICS INCChief financial officer Aug 15, 2022 to Aug 15, 2022²
RVL Pharmaceuticals plcChief financial officer Oct 18, 2018 to Jan 26, 2022³
PDS Biotechnology CorpChief financial officer Sep 30, 2015 to Mar 13, 2017⁴
MedAvail Holdings, Inc.Chief financial officer Oct 19, 2012 to Oct 19, 2012⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pelthos Therapeutics Inc. PTHS12,000 shares⁶$242.4K at $20.20Dec 23, 2025
RVL Pharmaceuticals plc164,325 shares⁷Jan 26, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 23, 2025Granted 12,000 shares of Pelthos Therapeutics Inc.⁶
Jan 24, 2022Shares withheld for tax 9,607 shares at $1.13 of RVL Pharmaceuticals plc⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPelthos Therapeutics Inc., Board member
2
SEC EDGARCOGNITION THERAPEUTICS INC, Chief financial officer
3
SEC EDGARRVL Pharmaceuticals plc, Chief financial officer
4
SEC EDGARPDS Biotechnology Corp, Chief financial officer
5
SEC EDGARMedAvail Holdings, Inc., Chief financial officer
6
SEC EDGARPelthos Therapeutics Inc. shares after the filing of Dec 23, 2025
7
SEC EDGARRVL Pharmaceuticals plc shares after the filing of Jan 26, 2022